Purdue University is holding a conference on November 8, 2007 from 9am to 5pm focusing on global business development in the field of life sciences. This event is free and requires a simple registration form be filled out prior to the event.
The Lilly Endowment, an Indianapolis-based company, provided Purdue University’s Discovery Park, Purdue’s hub for interdisciplinary research, to hold ongoing Discovery Lecture Series. United States physicist, John Hall, who won a Nobel Prize for his part in developing laser-based precision spectroscopy, has lectured in this series at Purdue University in the past. Other Discovery Lectures addressed topics of health care and nanotechnology.
This year’s Discovery Lecture focuses on life science business development. The Lecture is being held in conjunction with Purdue’s Kauffman Campus Imitative. G. Steven Burrill will give the keynote speech during the conference.
Steven Burrill owns his own company, Burrill and Company, a merchant bank focused on life sciences including biotechnology, healthcare, pharmaceuticals, nutraceuticals and wellness, industrial biotechnology, and agricultural biotechnology.
In addition to launching his own company, Burrill is also a board member of Catalyst Biosciences, Phytomedics, Intranasal, Targacept, Proteogenix, DepoMed, and XDX. Burrill is also the chairmen of Pharmasset, a pharmaceutical company.
Burrill began his own company in 1994, but before he did so, he worked at Ernst and Young where he worked with clients worldwide.
Steven Burrill will give his keynote speech, “Biotech 2007: A Global Transformation” in the Ross-Ade Pavilion at Purdue University at 12:15pm on November 8, 2007.
In addition to the keynote address given by Burrill, workshops and discussion panels will be held as part of the conference events.
At 9am, Ted Ashburn will lead a workshop entitled, “Skills for Success in the World of Business Development.” Following the workshop, Michael Kurek will talk about what it takes to be a successful entrapper. He is the former partner of Michigan-based Biotechnology Business Consultants, Inc.
A panel discussion will be held at 2:30pm and will be led by David Johnson, president and chief executive of BioCrossroads. In addition to David Johnson, Ted Ashburn, senior director of Genzyme Corporation, a pharmaceutical company, Steven Burrill, and Roger Newton, co-founder of Esperion Therapeutics, a subsidiary of Pfizer Corporation will also be on the panel.
Finally, Purdue University president France Cordova will talk about Purdue’s success in technology commercialization at 1:30pm.
While this event is free, individuals interested in attending the conference need to register ahead of time. You may register by visiting: http://www.purdue.edu/dp/dls/ and filling out the simple registration form on-line.
Purdue University: Discovery Lecture Series Focuses on Global Business Development in Life Sciences Arena:
Burrill & Company: About Burrill: